Initial therapy of chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Initial therapy of chronic lymphocytic leukemia

Published:2016-04 Issue:2 Volume:43 Page:241-250
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Eichhorst Barbara,Cramer Paula,Hallek Michael

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference100 articles.

1. Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia;Altman;Cancer,1956

2. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia;Han;Cancer,1973

3. Proceedings: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia;Knospe;Cancer,1974

4. CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study;Hansen;Nouv Rev Fr Hematol,1988

5. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone;Montserrat;Cancer,1985

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression;Molecular Biotechnology;2022-06-15

2. Radiopharmaceuticals for Relapsed or Refractory Leukemias;Frontiers in Oncology;2019-02-25

3. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia;Quality of Life Research;2017-11-10

4. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia;Journal of Hematology & Oncology;2017-05-19

5. Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number;Oncotarget;2017-03-13